Abstract
The aim of this study was to compare the effects of standard and immunomodulating enteral nutrition on the clinical outcomes of the patients undergoing major abdominal cancer surgery. Patients who underwent a major elective abdominal cancer surgery in our clinic were randomly assigned preoperatively to two groups according to enteral nutritional intervention; Standard (ST) or Immunomodulating (IM) group. The patients who were randomized to ST and IM groups received Resource® 2.0 fiber and OraI Impact® RTD 7 days prior to surgery and 30 days after surgery, respectively. The outcome variables were as follows; infections (surgical site infection, pneumonia, abdominal abscess or septicemia), non-infectious complications (wound dehiscence, anastomotic leak, adult respiratory distress syndrome (ARDS), multi-organ failure), need for intensive care unit admission, need for re-operation, length of hospital stay, and hospital mortality. A total of 78 patients were randomized (n = 39 in each group). Forty-five (58%) of patients were male and mean age was 62.9 ± 13.4 (25–85). The mean pre-operative Body Mass Index (BMI) and Nutritional Risk Screening (NRS-2002) scores were 26.5 ± 5.4 and 2.3 ± 1.1, respectively. There were no significant differences in gender, age, BMI, and NRS-2002 scores between groups (p ≥ 0.05). ASA scores, surgical interventions also were similar in two groups. Rate of surgical site infection in groups ST and IM was 72% (n = 28) and 15% (n = 6), (p < 0.001). Rate of pneumonia in groups ST and IM was 25% (n = 10) and 0% (n = 0), (p < 0.001). Rate of urinary tract infection in groups ST and IM was 33.3% (n = 13) and 5.1% (n = 2), (p < 0.03). Length of hospital stay in groups ST and IM was 8.4 ± 4.8 and 6.1 ± 1.4, respectively (p < 0,003). There were no significant differences in other outcome variables between groups (p ≥ 0.05, for all comparisons). Perioperative immunomodulating enteral nutrition may reduce the incidence of surgical site infection, pneumonia, urinary tract infection and length of hospital stays in patients who received abdominal cancer surgery.
Similar content being viewed by others
References
Fearon KC, Ljungqvist O, Von Meyenfeldt M et al (2005) Enhanced recovery after surgery: a consensus review of clinical care for patients undergoing colonic resection. Clin Nutr 24(3):466–477
Parks L, Routt M, De Villiers A (2018) Enhanced recovery after surgery. J Adv Pract Oncol 9(5):511–519
Jeong O, Kim HG (2019) Implementation of enhanced recovery after surgery (ERAS) program in perioperative Management of Gastric Cancer Surgery: a Nationwide survey in Korea. J Gastric Cancer 19(1):72–82
Arends J, Bachmann P, Baracos V, Barthelemy N, Bertz H, Bozzetti F, Fearon K, Hütterer E, Isenring E, Kaasa S, Krznaric Z, Laird B, Larsson M, Laviano A, Mühlebach S, Muscaritoli M, Oldervoll L, Ravasco P, Solheim T, Strasser F, de van der Schueren M, Preiser JC (2017) ESPEN guidelines on nutrition in cancer patients. Clin Nutr 36(1):11–48
Braga M, Gianotti L, Radaelli G et al (1999) Perioperative immunonutrition in patients undergoing cancer surgery: results of a randomized double-blind phase 3 trial. Arch Surg 134(4):428–433
Cerantola Y, Grass F, Cristaudi A et al (2011) Perioperative nutrition in abdominal surgery: recommendations and reality. Gastroenterol Res Pract 2011:739347
Lohsiriwat V (2019) Learning curve of enhanced recovery after surgery program in open colorectal surgery. World J Gastrointest Surg 11(3):169–178
Waitzberg DL, Saito H, Plank LD, Jamieson GG, Jagannath P, Hwang TL, Mijares JM, Bihari D (2006) Postsurgical infections are reduced with specialized nutrition support. World J Surg 30(8):1592–1604
Adiamah A, Skořepa P, Weimann A, Lobo DN (2019) The impact of preoperative immune modulating nutrition on outcomes in patients undergoing surgery for gastrointestinal Cancer: a systematic review and meta-analysis. Ann Surg 270(2):247–256
Strickland A, Brogan A, Krauss J, Martindale R, Cresci G (2005) Is the use of specialized nutritional formulations a cost-effective strategy? A national database evaluation. JPEN J Parenter Enteral Nutr 29(1 Suppl):S81–S91
Bozzetti F, Forbes A (2009) The ESPEN clinical practice guidelines on parenteral nutrition: present status and perspectives for future research. Clin Nutr 28(4):359–364
Weimann A, Braga M, Carli F et al (2017) ESPEN guideline: clinical nutrition in surgery. Clin Nutr 36(3):623–650
Braga M, Gianotti L, Gentilini O, Liotta S, di Carlo V (2002) Feeding the gut early after digestive surgery: results of a nine-year experience. Clin Nutr 21(1):59–65
Volkert D, Beck AM, Cederholm T, Cruz-Jentoft A, Goisser S, Hooper L, Kiesswetter E, Maggio M, Raynaud-Simon A, Sieber CC, Sobotka L, van Asselt D, Wirth R, Bischoff SC (2019) ESPEN guideline on clinical nutrition and hydration in geriatrics. Clin Nutr 38(1):10–47
Cerantola Y, Hübner M, Grass F, Demartines N, Schäfer M (2011) Immunonutrition in gastrointestinal surgery. Br J Surg 98(1):37–48
Kompan L, Vidmar G, Spindler-Vesel A et al (2004) Is early enteral nutrition a risk factor for gastric intolerance and pneumonia? Clin Nutr 23(4):527–532
Daly JM, Redmond HP, Gallagher H (1992) Perioperative nutrition in cancer patients. JPEN J Parenter Enteral Nutr 16(6 Suppl):100S–105S
Marik PE, Flemmer M (2012) Immunonutrition in the surgical patient. Minerva Anestesiol 78(3):336–342
Marik PE, Zaloga GP (2010) Immunonutrition in high-risk surgical patients: a systematic review and analysis of the literature. JPEN J Parenter Enteral Nutr 34(4):378–386
Pacelli F, Bossola M, Papa V, Malerba M, Modesti C, Sgadari A et al (2001) EN-TPN Study Group. Enteral vs parenteral nutrition after major abdominal surgery: an even match. Arch Surg 136(8):933–936
Marimuthu K, Varadhan KK, Ljungqvist O, Lobo DN (2012) A meta-analysis of the effect of combinations of immune modulating nutrients on outcome in patients undergoing major open gastrointestinal surgery. Ann Surg 255(6):1060–1068
Klek S, Szybinski P, Szczepanek K (2014) Perioperative immunonutrition in surgical cancer patients: a summary of a decade of research. World J Surg 38(4):803–812
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Informed Consent
Informed consents were obtained from the patients.
Conflict of Interest
No conflict of interest was declared by the authors.
Financial Disclosure
The authors declared that this study has received no financial support.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Yeğen, S.F., Kafadar, M.T. & Gök, M.A. Comparison of Perioperative Standard and Immunomodulating Enteral Nutrition in Patients Received Major Abdominal Cancer Surgery: a Prospective, Randomized, Controlled Clinical Trial. Indian J Surg 82, 828–834 (2020). https://doi.org/10.1007/s12262-020-02114-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12262-020-02114-0